Neoadjuvant chemotherapy with CPT-11 and cisplatin downstages locally advanced gastric cancer

Journal of Gastrointestinal Surgery

Volumn 6, Issue 2, 2002, Pages 212-223

  Newman, Elliot ^a,b   Marcus, Stuart G ^a   Potmesil, Milan ^a   Sewak, Sanjeev ^a   Yee, Herman ^a   Sorich, Joan ^a   Hayek, Mary ^a   Muggia, Franco ^a   Hochster, Howard ^a   Velanovich, V ^c   Kelly, K ^c   Zenilman, M ^c   Fink, V ^c   Pellegrini, C ^c  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^c NONE

Author keywords

Downstaging; Gastric cancer; Neoadjuvant therapy

Indexed keywords

ANTICOAGULANT AGENT; ATROPINE; CARBOPLATIN; CISPLATIN; DEXAMETHASONE; FLOXURIDINE; GRANULOCYTE COLONY STIMULATING FACTOR; IRINOTECAN; LOPERAMIDE; NONIONIC CONTRAST MEDIUM; OXYCODONE; PARACETAMOL; RECOMBINANT ERYTHROPOIETIN; SEROTONIN 3 ANTAGONIST; ANTINEOPLASTIC AGENT; CAMPTOTHECIN; DRUG DERIVATIVE;

ABDOMINAL PAIN; ADULT; ADVANCED CANCER; AGED; ANAPHYLAXIS; ANASTOMOSIS LEAKAGE; ANEMIA; ANOREXIA; ANTICOAGULANT THERAPY; ARTICLE; BLOOD TOXICITY; CANCER ADJUVANT THERAPY; CANCER DIAGNOSIS; CANCER PALLIATIVE THERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CHOLINERGIC SYSTEM; CLINICAL ARTICLE; CLINICAL EXAMINATION; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DEHYDRATION; DEVICE INFECTION; DIARRHEA; DISEASE COURSE; DRUG DELIVERY SYSTEM; DRUG DOSE REGIMEN; DRUG HYPERSENSITIVITY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; ECHOGRAPHY; FATIGUE; FEBRILE NEUTROPENIA; FEMALE; FOLLOW UP; GASTRECTOMY; GASTROSCOPY; HISTOLOGY; HOSPITALIZATION; HUMAN; INFORMED CONSENT; KIDNEY DYSFUNCTION; LAPAROSCOPY; LIVER METASTASIS; LIVER RESECTION; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MALE; MORBIDITY; MUSCLE ATONIA; NAUSEA; NEUROPATHY; NEUTROPENIA; PERITONITIS; POSTOPERATIVE COMPLICATION; PREOPERATIVE PERIOD; RASH; RECURRENT CANCER; SEPSIS; SIDE EFFECT; STOMACH ADENOCARCINOMA; SUPERIOR CAVA VEIN SYNDROME; SURGICAL MORTALITY; THROMBOCYTOPENIA; TREATMENT PLANNING; VOMITING; ADENOCARCINOMA; ADJUVANT THERAPY; DISEASE FREE SURVIVAL; INTRAPERITONEAL DRUG ADMINISTRATION; METASTASIS; MIDDLE AGED; MORTALITY; NEEDLE BIOPSY; PATHOLOGY; PHASE 2 CLINICAL TRIAL; STOMACH TUMOR; SURVIVAL RATE; TREATMENT OUTCOME;

ADENOCARCINOMA; ADULT; AGED; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BIOPSY, NEEDLE; CAMPTOTHECIN; CISPLATIN; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; GASTRECTOMY; GASTROSCOPY; HUMANS; INJECTIONS, INTRAPERITONEAL; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM METASTASIS; NEOPLASM STAGING; STOMACH NEOPLASMS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 19044364838     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1091-255X(01)00054-3     Document Type: Article

References (35)

1. Pisani P, Parkin DM, Bray F, Ferlay J. Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer 1999;83:18-29.
2. Greenlee RT, Hill-Harmon MB, Murray T, Thun M. Cancer Statistics, 2001. CA Cancer J Clin 2001;51:15-36.
3. Blot WJ, Devesa SS, Kneller RW, Fraumeni JF. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 1991;265:1287-1289.
4. Shimada K, Ajani J. Adjuvant therapy for gastric carcinoma patients in the past 15 years: A review of Western and Oriental trials. Cancer 1999;86:1657-1668.
5. Cirera L, Balil A, Batiste-Alentorn E, Tusquets I, Cardona T, Arcusa A, Jolis L, Saigi E, Guasch I, Badia A, Boleda M. Randomized clinical trial of adjuvant mitomycin plus tegafur in patients with resected stage III gastric cancer. J Clin Oncol 1999;17:3810-3815.
6. Neri B, Cini G, Andreoli F, Boffi B, Francesconi D, Mazzanti R, Medi F, Mercatelli A, Romano S, Siliani L, Tarquini R, Moretti R. Randomized trial of adjuvant chemotherapy versus control after curative resection for gastric cancer: 5-year follow-up. Br J Cancer 2001;84:878-880.
7. MacDonald JS, Smalley S, Benedetti J,Estes N, Haller DG, Ajani JA, Gunderson LL, Jessup M, Martenson JA SWOG; ECOG; RTOG; CALGB; NCCTG. Postoperative combined radiation and chemotherapy improves disease-free survival and overall survival in resected adenocarcinoma of the stomach and G.E. junction. Results of Intergroup Study INT-0116 (SWOG 9008). Proceedings of the American Society of Clinical Oncology 2000; Abstract No. 1.
8. Ajani JA, Baker J, Pisters PW, Ho L, Feig B, Mansfield PF. CPT-11 plus cisplatin in advanced gastric or gastroesophageal junction carcinoma. Oncology (Huntingt) 2001; 15(Suppl 5):52-54.
9. Gallardo-Rincon D, Onate-Ocana LF, Calderillo-Ruiz G. Neoadjuvant chemotherapy with P-ELF (cisplatin, etoposide, leucovorin, 5-fluorouracil) followed by radical resection in patients with initially unresectable gastric adenocarcinoma: A phase II study. Ann Surg Oncol 2000;7:45-50.
10. Crookes P, Leichman CG, Leichman L, Tan M, Laine L, Stain S, Baranda J, Casagrande Y, Groshen S, Silberman H. Systemic chemotherapy for gastric carcinoma followed by postoperative intraperitoneal therapy: A final report. Cancer 1997;79:1767-1775.
11. Kelsen D, Karpeh M, Schwartz G, Gerdes H, Lightdale C, Botet J, Lauers G, Klimstra D, Huang Y, Saltz L, Quan V, Brennan M. Neoadjuvant therapy of high-risk gastric cancer: A phase II trial of preoperative FAMTX and postoperative intraperitoneal fluorouracil-cisplatin plus intravenous fluorouracil. J Clin Oncol 1996;14:1818-1828.
12. Ozer H, Armitage JO, Bennett CL, Crawford J, Demetri GD, Pizzo PA, Schiffer CA, Smith TJ, Somlo G, Wade JC, Wade JL III, Winn RJ, Wozniak AJ, Somerfield MR. 2000 update of recommendations for the use of hematopoietic colony-stimulating factors: Evidence-based, clinical practice guidelines. American Society of Clinical Oncology Growth Factor Expert Panel. J Clin Oncol 2000; 8:3558-3585.
13. Beseth BD, Bedford R, Isacoff WH, Holmes EC, Cameron RB. Endoscopic ultrasound does not accurately assess pathologic stage of esophageal cancer after neoadjuvant chemoradiotherapy. Am Surg 2000;66:827-831.
14. Japanese Research Society for Gastric Cancer. The general rules for the gastric study in surgery and pathology. Jpn J Surg 1981;11:127-137.
15. American Joint Committee on Cancer Staging Handbook. AJCC Cancer Staging Manual, 5th ed. Philadelphia: Lippincott-Raven, 1998; pp 71-75.
16. Muggia FM, LePoidevin E, Jeffers S, Russell C, Boswell W, Morrow CP, Curtin J, Schlaerth J. Intraperitoneal therapy for ovarian cancer: Analysis of fluid distribution by computerized tomography. Ann Oncol 1992;3:149-154.
17. Muggia FM, Jeffers S, Muderspach L, Roman L, Rosales R, Groshen S, Safra T, Morrow CP. Phase I/II study of intraperitoneal floxuridine and platinums (cisplatin and/or carboplatin). Gynecol Oncol 1997;66:290-294.
18. Wanebo HJ, Kennedy BJ, Chmiel J, Steele G Jr, Winchester D, Osteen R. Cancer of the stomach. A patient care study by the American College of Surgeons. Ann Surg 1993;218:583-592.
19. Lowy AM, Leach SD. Adjuvant/neoadjuvant chemoradiation for gastric and pancreatic cancer. Oncology 1999;13(Suppl 5):121-130.
20. Kelsen D. Neoadjuvant therapy for upper gastrointestinal tract cancers. Curr Opin Oncol 1996;8:321-328.
21. Futatsuki K, Wakui A, Nakao I, Sakata Y, Kambe M, Shimada Y, Yoshino M, Taguchi T, Ogawa N. Late phase II study of CPT-11 hydrochloride (CPT-11) in advanced gastric cancer. CPT-11 Gastrointestinal Cancer Study Group. Gan To Kagaku Ryoho 1994;2:1033-1038 [in Japanese].
22. Boku N, Ohtsu A, Shimada Y, Shirao K, Seki S, Saito H, Sakata Y, Hyodo I. Phase II study of a combination of CPT-11 and cisplatin against metastatic gastric cancer. J Clin Oncol 1999;17:319-323.
23. Saltz LB, Spriggs D, Schaaf LJ, Schwartz GK, Ilson D, Kemeny N, Kanowitz J, Steger C, Eng M, Albanese P, Semple D, Hanover CK, Elfring GL, Miller LL, Kelsen D. Phase I clinical and pharmacologic study of weekly cisplatin combined with weekly CPT-11 in patients with advanced solid tumors. J Clin Oncol 1998;16:3858-3865.
24. Heberer G, Teichmann RK, Kramling HJ, Gunther B. Results of gastric resection for carcinoma of the stomach: The European experience. World J Surg 1988;12:374-381.
25. Roder JD, Bottcher K, Siewert JR, Busch R, Hermanek P, Meyer HJ. Prognostic factors in gastric carcinoma. Results of the German Gastric Carcinoma Study; 1992. Cancer 1993;72:2089-2097.
26. Ajani JA, Mansfield PF, Lynch PM, Pisters PW, Feig B, Dumas P, Evans DB, Raijman I, Hargraves K, Curley S, Ota DM. Enhanced staging and all chemotherapy preoperatively in patients with potentially resectable gastric carcinoma. J Clin Oncol 1999;17:2403-2411.
27. Bosset JF, Gignoux M, Triboulet JP, Tiret E, Mantion G, Elias D, Lozach P, Ollier JC, Pavy JJ, Mercier M, Sahmoud T. Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. N Engl J Med 1997;337:161-167.
28. Kelsen DP, Ginsberg R, Pajak TF, Sheahan DG, Gunderson L, Mortimer J, Estes N, Haller DG, Ajani J, Kocha W, Minsky BD, Roth JA. Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Engl J Med 1998;339:1979-1984.
29. Caletti G, Fusaroli P. Endoscopic ultrasonography [review]. Endoscopy 2001;33:158-166.
30. Stell DA, Carter CR, Stewart I, Anderson JR. Prospective comparison of laparoscopy, ultrasonography and computed tomography in the staging of gastric cancer. Br J Surg 1996;83:1260-1262.
31. D'Elia F, Zingarelli A, Palli D, Grani M. Hydro-dynamic CT preoperative staging of gastric cancer: Correlation with pathological findings. A prospective study of 107 cases. Eur Radiol 2000;10:1877-1885.
32. D'Ugo DM, Coppola R, Persiani R, Ronconi P, Caracciolo F, Picciocchi A. Immediately preoperative laparoscopic staging for gastric cancer. Surg Endosc 1996;10:996-999.
33. Lowy AM, Mansfield PF, Leach SD, Ajani J. Laparoscopic staging for gastric cancer. Surgery 1996;119:611-614.
34. Burke EC, Karpeh MS, Conlon KC, Brennan MF. Laparoscopy in the management of gastric adenocarcinoma. Ann Surg 1997;225:262-267.
35. Lowy AM, Mansfield PF, Leach SD, Pazdur R, Dumas P, Ajani JA. Response to neoadjuvant chemotherapy best predicts survival after curative resection of gastric cancer. Ann Surg 1999;229:303-308.